Latka logo

Eleven Labs vs Genviral: Revenue, Funding & Team Size Compared

Eleven Labs generates $500M in revenue; Genviral has not disclosed its revenue. The table below compares Eleven Labs and Genviral on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Eleven Labs vs Genviral compared on revenue, funding, valuation, customers and team size
CompanyEleven Labs logoEleven LabsThis companyGenviral logoGenviral
Revenue$500MNot disclosed
Valuation$11BNot disclosed
Funding raised$881MNot disclosed
Team size400Not disclosed
Growth51.5%Not disclosed
Founded20222025
HQNew York City, United StatesBelgium

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Eleven Labs logo

Eleven Labs at a glance

Eleven Labs generates $500M in revenue with 400 employees, headquartered in New York City, United States.

Revenue
$500M
Valuation
$11B
Funding
$881M
Team size
400
Founded
2022

Research Lab: Exploring new frontiers of voice generation. We are dedicated to researching and implementing innovative techniques in voice artificial intelligence (AI) to enhance the appeal of content across different languages and voices…

Genviral logo

Genviral at a glance

Founded
2025

Genviral is an AI-powered content automation platform that streamlines the creation and posting of short-form social media content across TikTok, Instagram Reels, Facebook, YouTube Shorts, and more. Founded by Viktor and Fekri and built…

Other Eleven Labs alternatives

Eleven Labs competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Eleven Labs vs Genviral: frequently asked questions

How much revenue does Eleven Labs make?

Eleven Labs generates $500M in annual revenue with a team of 400.

How much funding has Eleven Labs raised?

Eleven Labs has raised $881M in total funding since it was founded in 2022.